These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9934543)

  • 61. [Clinical experience with cefixime in the pediatric infections].
    Furukawa S; Okada T
    Jpn J Antibiot; 1986 Apr; 39(4):1128-37. PubMed ID: 3761541
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
    Jauregui L; Minns P; Hageage G
    J Chemother; 1995 Apr; 7(2):153-6. PubMed ID: 7666123
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [The study of flomoxef in the pediatric field].
    Sato H; Narita A; Nakazawa S; Suzuki H; Mastumoto K; Nakanishi Y; Nakazawa S; Niino K; Nakada Y
    Jpn J Antibiot; 1987 Aug; 40(8):1349-63. PubMed ID: 3430712
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ampicillin/sulbactam compared with cefotaxime in the treatment of lower respiratory tract infections of bacterial etiology.
    Jauregui L; Minns P; Hageage G
    Adv Ther; 1995; 12(1):62-71. PubMed ID: 10150322
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Overview of the clinical features of cefixime.
    Adam D
    Chemotherapy; 1998 Sep; 44 Suppl 1():1-5. PubMed ID: 9797415
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Effect of cefotaxime in the treatment of infections associated with hematologic diseases].
    Kaneko H; Masaki T; Yamaguchi R; Takahashi N; Umeda M; Shirai T
    Jpn J Antibiot; 1983 Sep; 36(9):2502-14. PubMed ID: 6317914
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Clinical evaluation of cefotaxime in internal medicine].
    Konishi K; Takishima T; Honda I; Kumagaya A; Kanazawa Y; Muranaka M; Yoshida Y; Kanazawa T; Takahashi H; Honma M
    Jpn J Antibiot; 1983 Jul; 36(7):1653-75. PubMed ID: 6317910
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cefotaxime therapy of lower respiratory tract infections in intensive-care patients.
    Rondanelli R; Dionigi RV; Calvi M; Dell'Antonio M; Corsico G; Mapelli A
    Int J Clin Pharmacol Res; 1987; 7(1):73-6. PubMed ID: 3583490
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cefpodoxime proxetil. An appraisal of its use in antibacterial cost-containment programmes, as stepdown and abbreviated therapy in respiratory tract infections.
    Balfour JA; Benfield P
    Pharmacoeconomics; 1996 Aug; 10(2):164-78. PubMed ID: 10163419
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Population Pharmacokinetics of Cefotaxime and Dosage Recommendations in Children with Sickle Cell Disease.
    Maksoud E; Koehl B; Facchin A; Ha P; Zhao W; Kaguelidou F; Benkerrou M; Mariani P; Faye A; Lorrot M; Jacqz-Aigrain E
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378711
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial.
    Li JT; Lu Y; Hou J; Chen YF; Miao JZ; Jia YX; Hou J; Zhang XZ; Chen DK; Hu WZ; Li LJ; Liu DM; Wang Z; Wu J; Gu JM; Wang HL; Zhang YL; Sun L
    Clin Infect Dis; 1997 Mar; 24(3):498-505. PubMed ID: 9114206
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Comparative study of the effectiveness of cefotaxime and cefazolin on respiratory tract infection (author's transl)].
    Kansenshogaku Zasshi; 1980 Sep; 54(9):471-517. PubMed ID: 6263989
    [No Abstract]   [Full Text] [Related]  

  • 73. Efficacy of twice-daily amoxycillin/clavulanate ('Augmentin-Duo' 400/57) in mild to moderate lower respiratory tract infection in children.
    Cook RC; Zachariah J; Cree F; Harrison HE
    Br J Clin Pract; 1996; 50(3):125-8. PubMed ID: 8733329
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Clinical evaluation of cefixime in children].
    Meguro H; Arimasu O; Sohda H; Yoshida J; Togasaki K; Fujii R
    Jpn J Antibiot; 1986 Apr; 39(4):1007-19. PubMed ID: 3761534
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Clinical experience with cefodizime in pediatric field].
    Sekiguchi T; Okamoto T; Ohara K; Kouzan H; Nishimori M; Miyazaki M
    Jpn J Antibiot; 1989 Jun; 42(6):1391-8. PubMed ID: 2795863
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparative evaluation of cefmenoxime versus cefoxitin in serious infections.
    Bechard DL; Hawkins SH; Sutherland SC
    Am J Med; 1984 Dec; 77(6A):13-6. PubMed ID: 6097117
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacokinetics of cefotaxime in healthy volunteers and patients.
    Patel KB; Nicolau DP; Nightingale CH; Quintiliani R
    Diagn Microbiol Infect Dis; 1995; 22(1-2):49-55. PubMed ID: 7587050
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Clinical and pharmacokinetic evaluation of ceftriaxone in children].
    Fujita K; Sakata H; Murono K; Yoshioka H; Maruyama S; Sanae N
    Jpn J Antibiot; 1984 Dec; 37(12):2271-82. PubMed ID: 6098720
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections.
    Neu HC; Chick TW
    Chest; 1993 Nov; 104(5):1393-9. PubMed ID: 8222794
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cefotaxime in lower respiratory tract infections compared to cefazolin.
    Miki F; Shiota K
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():169-75. PubMed ID: 6252151
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.